Association between antiseizure medications and quality of life in epilepsy: A mediation analysis
Article 2021 en
Authors
MW
Meng Wang
KP
Kevin Perera
CJ
Colin B. Josephson
Abstract
1 min read
These findings highlight the importance of managing depression and ASM side effects for improving health outcomes of patients requiring treatment with ASMs. Intervention programs aimed at improving HRQOL of patients with epilepsy need to target these potential mediators.
Anna Panasewicz, Susanne S. Pedersen, Stefanie J.G. Veenhuis, Rohit M. Oemrawsingh, Wim J. van der Giessen, Robert‐Jan van Geuns, Evelyn Regar, Peter P. de Jaegere, Patrick W. Serruys, Ron T. van Domburg
Laura C. Coates, Valderílio Feijó Azevedo, Joseph C. Cappelleri, Jade Moser, Lihi Eder, Pascal Richette, Meng‐Yu Weng, Rubén Queiró, Amit Garg, Amar Majjhoo, Christopher Em Griffiths, Pamela Young, Samantha Howland
Niels Janssen, Ron Handels, Anders Wimo, Riitta Antikaínen, Tiina Laatikainen, Hilkka Soininen, Timo Strandberg, Jaakko Tuomilehto, Miia Kivipelto, Silvia M. A. A. Evers, Frans R.J. Verhey, Tiia Ngandu
Meaghan Lunney, Sandra Wahby, Khara M. Sauro, Mark J. Atkinson, Colin B. Josephson, Fady Girgis, Shaily Singh, Scott Burton Patten, Nathalie Jetté, Tolulope T. Sajobi, Walter Hader, Samuel Wiebe
Discussion(0)
No comments yet. Be the first to comment.